Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Understanding Your EXOC2 Genetic Result and Skin Cancer Risk

Skin cancer is common and strongly influenced by sun exposure as well as inherited genetics. Variations near the EXOC2 gene on chromosome 6 have been associated with changes in skin pigmentation, vitamin D levels, and susceptibility to non-melanoma skin cancers, specifically basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Your genetic result for the rs12210050 variant helps clarify whether you carry the T risk allele linked to higher likelihood of these cancers.

How genetics and environment work together

Genes can change your baseline susceptibility, but everyday choices and exposures typically have the largest influence on whether skin cancer develops. UV radiation from the sun and indoor tanning damages skin DNA and is the dominant modifiable risk factor for BCC and SCC. Knowing your genotype can motivate targeted prevention and earlier screening, but it does not determine fate.

Simple, practical prevention steps

  • Use a broad spectrum sunscreen with SPF 30 or higher on exposed skin and reapply every two hours when outdoors. Apply more often after swimming or sweating.
  • Wear sun-protective clothing, a wide brim hat, and UV-blocking sunglasses.
  • Avoid intentional tanning and tanning beds entirely.
  • Seek shade between 10 a.m. and 4 p.m. when UV rays are strongest.
  • Perform monthly self-skin checks to look for new growths, spots that change, or wounds that do not heal. Photograph concerning areas to track change.
  • See a dermatologist for annual skin exams or sooner if you notice suspicious changes.

Nutrition, supplements, and skin health

A diet that supports skin resilience and repair can complement sun protection. Focus on whole foods rich in antioxidants, essential fats, and adequate hydration.

  • Eat a variety of colorful fruits and vegetables to supply vitamin C, carotenoids, polyphenols, and other antioxidants that help reduce oxidative stress from UV exposure.
  • Include sources of omega-3 fatty acids, such as fatty fish, walnuts, chia seeds, or algae-based supplements. Omega-3s can support skin barrier function and reduce inflammation.
  • Ensure adequate dietary or supplemental vitamin D if you have limited sun exposure. EXOC2 variants can influence vitamin D status, so check levels before beginning supplements.
  • Stay well hydrated to support skin elasticity and repair.
  • Consider discussing antioxidant supplements like vitamin C, vitamin E, or carotenoids with your healthcare provider if dietary intake is low.

Lifestyle and monitoring recommendations

  • Limit smoking and excessive alcohol use, as these impair skin healing and immune function.
  • Manage chronic inflammation through a balanced diet, regular physical activity, and adequate sleep.
  • Keep a record of moles and spots with photos. Share any rapid changes or symptomatic lesions with your clinician promptly.
  • If you spend extended time outdoors for work or recreation, implement an intensified sun safety routine and consider protective fabrics rated for UV protection.

Recommended blood tests and clinical follow up

  • Vitamin D (25-hydroxyvitamin D) to assess need for supplementation, particularly if you avoid sun exposure or have risk variants that influence vitamin D levels.
  • Discuss with your clinician whether regular dermatologic surveillance is appropriate based on your skin type, history of sunburns, prior skin cancers, and family history.

Genetic Interpretation

Two effect alleles (TT) — increased risk

If you have the TT genotype for rs12210050, you carry two copies of the T effect allele. This genotype has been associated with an increased risk of non-melanoma skin cancers, specifically basal cell carcinoma and squamous cell carcinoma. Variants near EXOC2 are thought to influence processes related to skin pigmentation and vitamin D metabolism, which can modify how skin responds to UV damage.

What to do

  • Adopt strict sun protection habits: daily broad spectrum sunscreen, protective clothing, hats, and shade.
  • Perform monthly self skin checks and schedule more frequent dermatologist visits for professional skin exams.
  • Test and optimize vitamin D levels in consultation with your provider before starting supplements.
  • Emphasize antioxidant-rich foods and consider discussing targeted supplementation with your clinician.
One effect allele (CT) — likely increased risk

If you have the CT genotype for rs12210050, you carry one copy of the T effect allele. This genotype is associated with a likely increased risk for basal cell carcinoma and squamous cell carcinoma compared to non-carriers, though the increase in risk is typically more modest than with two copies.

What to do

  • Follow consistent sun safety practices and avoid tanning beds.
  • Perform regular self-exams and discuss skin screening frequency with your healthcare provider based on other risk factors.
  • Check vitamin D status if you limit sun exposure and talk with your clinician about diet or supplements if levels are low.
  • Focus on a diet high in antioxidants and omega-3 fatty acids to support skin repair and reduce inflammation.
No effect alleles (CC) — typical genetic risk

If you have the CC genotype for rs12210050, you carry two copies of the non-effect C allele. Your inherited genetic risk at this particular site is not elevated. However, common non-genetic factors such as UV exposure, skin type, number of sunburns, and lifestyle remain important determinants of skin cancer risk.

What to do

  • Maintain strong sun protection and regular skin checks because standard prevention reduces risk for everyone.
  • Adopt a skin-supporting diet, stay hydrated, and consider vitamin D testing if you have low sun exposure.
  • Seek dermatology evaluation for any concerning lesions or if you have personal or family history of skin cancer.

Putting this information into practice

Your rs12210050 result can guide how proactive you want to be about sun protection and monitoring. If you carry one or two T alleles, increasing the frequency of skin checks and working closely with a dermatologist are reasonable steps. Regardless of genotype, the most effective actions remain avoiding excessive UV exposure and adopting protective behaviors.

Important disclaimer

PlexusDx provides educational information about genetic predispositions only. This content is not medical advice. Always consult your healthcare provider or a qualified clinician before making decisions about screening, diagnosis, or treatment. Your provider can interpret this genetic information in the context of your medical history, skin type, family history, and overall health.


If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:


Frequently Asked Questions About SKIN CANCER and EXOC2 rs12210050

What does the EXOC2 rs12210050 T risk allele mean for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) risk?

The EXOC2 rs12210050 variant is associated with increased susceptibility to non-melanoma skin cancers, particularly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). If your results show one T effect allele (CT) or two T effect alleles (TT), your genetic risk at this site is higher than if you carry no T effect alleles (CC), which is considered typical genetic risk.

Does the rs12210050 genotype determine whether I will develop skin cancer?

No. Although the rs12210050 genotype can clarify baseline susceptibility, UV exposure is the dominant modifiable driver of BCC and SCC. Daily sun protection, avoiding tanning beds, and consistent skin monitoring are the most effective actions regardless of genotype—genetics mainly helps you decide how proactive to be with prevention and screening.

How should I use my rs12210050 result to guide prevention, vitamin D, and follow-up care?

If you carry one or two T alleles, it’s reasonable to adopt stricter sun safety, perform monthly self-skin checks, and discuss more frequent dermatologist surveillance with your clinician. Because EXOC2 variants can influence vitamin D levels, ask about checking 25-hydroxyvitamin D before starting supplements, especially if you limit sun exposure. Support skin resilience with an antioxidant-rich diet, omega-3 sources, hydration, and consider supplementation only with clinician guidance if dietary intake is low.

What tests can help me learn more about SKIN CANCER and EXOC2 rs12210050?

The Longevity and Healthy Aging Genetic Test delivers over 200 genetic insights related to cellular repair, inflammation balance, metabolism, cardiometabolic health, and aging pathways. The Healthy Aging Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.


Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.